Overview
Product name | Recombinant SARS-COV-2 Nucleocapsid(D63G, R203M, D377Y) Protein |
---|
Catalog No. | RP01474LQ |
---|
Description | Recombinant SARS-COV-2 Nucleocapsid(D63G, R203M, D377Y) Protein is produced by E. coli expression system. The target protein is expressed with sequence (Ser2-Ala419(D63G, R203M, D377Y)) of sars-cov-2 Nucleocapsid(D63G, R203M, D377Y) (Accession #QHD43423.2) fused with an 6×His tag at the N-terminus. |
---|
Bio-Activity | Measured by its binding ability in a functional ELISA.Immobilized SARS-CoV-2 Envelope at 2 μg/mL (100 μL/well) can bind SARS-COV-2 Nucleocapsid with a linear range of 0.01-30 ng/mL.
|
---|
Purity | > 95% by SDS-PAGE.> 95% by HPLC. |
---|
Endotoxin | <0.1EU/μg |
---|
Formulation | Supplied as a 0.22 μm filtered solution in 20mM Tris, 500mM NaCl, 0.1mM EDTA, 10% glycerol, pH8.0. |
---|
Species | SARS-COV-2 |
---|
Calculated MW | 46.30 kDa |
---|
Product information
Synonym | Nucleoprotein |
---|
Expression Host | E. coli |
---|
Tag | N-his |
---|
Gene ID | |
---|
Usage guide
Storage | Store at -70℃. This product is stable at ≤ -70℃ for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles. |
---|
* For research use only. Not for therapeutic or diagnostic purposes.